Liraglutide was finally approved in 2010 for the treatment of patients with type 2 diabetes unable to regulate their blood sugar with other insulin medications (Gilbert, Rosenthal, Jan 2024)
Bartelt K, Mast C, Deckert J, Gracianette M, Joyce B
Block quote Ordered list Item 1 Item 2 Item 3 Unordered list Item A Item B Item C Bold text Emphasis Superscript Subscript Real patients, real results Vanessa lost 53 lbs in 9 months Kathy lost 42 lbs in 6 months Tara lost 72 lbs in 12 months Mary Jane lost 40 lbs in 5 months Jeanine lost 57 lbs in 6 months Cynthia lost 74 lbs in 6 months Patricia lost 36 lbs in 8 months Robin lost 85 lbs in 9 months Laurel lost 56 lbs in 7 months Join our weight loss program in Midland
Key timing considerations: Morning injection produces peak appetite suppression around mid-afternoon to evening, ideal for those who struggle with afternoon snacking and dinner portions Evening injection produces peak levels overnight and through the morning, beneficial for those who overeat at breakfast or need better fasting glucose control The 13-hour half-life means effects noticeably diminish in the latter half of each 24-hour cycle Consistency is absolutely critical with daily dosing because missed doses create more significant gaps in drug levels Many liraglutide users tie their injection to a specific daily habit (brushing teeth, morning coffee ritual) to prevent missed doses Dulaglutide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 24 to 72 hours after injection Recommended timing approach: Similar pharmacokinetic profile to tirzepatide in terms of half-life, though the mechanism is pure GLP-1 agonism
.png)
